Relay Therapeutics is trading 5.15% down now at $19.51, with the catalyst unconfirmed.
- No clear company-specific announcement, earnings release, regulatory action, or analyst change was identified for August 26, 2026.
- The latest company results were released August 6; available reporting showed positive biotech sentiment, making sector weakness an unlikely explanation.
- The decline appears unexplained and potentially position-specific.